AVDV vs XBI
Avantis International Small Cap Value ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.36% for AVDV.
- • AVDV pays a higher dividend yield (2.83%).
Side-by-side metrics
| Metric | AVDV | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.36% | 0.35% |
Dividend yield Trailing 12-month yield. | 2.83% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $19.22B | $10.73B |
YTD return | 11.26% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.96 | 1.10 |
P/E ratio | 13.41 | — |
Last price | $103.29 | $164.01 |
Inception | — | — |
Issuer | Avantis | State Street |
AVDV top holdings
| ATS.VI | AT&S Austria Technologie & Systemtechnik AG | 2.56% |
| 5706.T | Mitsui Kinzoku Co Ltd | 1.17% |
| SPM.MI | Saipem SpA | 0.59% |
| PRU.AX | Perseus Mining Ltd | 0.57% |
| CLIS.TA | Clal Insurance Enterprises Holdings Ltd | 0.56% |
| JMAT.L | Johnson Matthey PLC | 0.56% |
| BTO.TO | B2Gold Corp | 0.55% |
| BGEO.L | Lion Finance Group PLC | 0.55% |
| CDE | Coeur Mining Inc | 0.54% |
| HBM.TO | Hudbay Minerals Inc | 0.53% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About AVDV
AVDV (Avantis International Small Cap Value ETF) is International developed small-cap value stocks. Managed by Avantis, the fund carries $19.2B in assets under management, an expense ratio of 0.36%, a dividend yield of 2.83%. Its largest holding is AT&S Austria Technologie & Systemtechnik AG (ATS.VI), which represents 2.6% of the portfolio. Real Estate is the fund's largest sector exposure at 1.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.